^SAMPLE = GSM590107!Sample_title = KPL4 genomic DNA!Sample_geo_accession = GSM590107!Sample_status = Public on Jan 11 2011!Sample_submission_date = Sep 02 2010!Sample_last_update_date = Jan 12 2011!Sample_type = genomic!Sample_channel_count = 2!Sample_source_name_ch1 = pooled genomic DNA from healthy female donors!Sample_organism_ch1 = Homo sapiens!Sample_taxid_ch1 = 9606!Sample_characteristics_ch1 = sample type: pooled genomic DNA from healthy female donors!Sample_characteristics_ch1 = gender: female!Sample_growth_protocol_ch1 = MCF-7, KPL-4 and BT-474 cells were maintained in DMEM supplemented with 10% FBS, 2 mM (MCF-7, KPL-4) or 4 mM (BT-474) L-glutamine and penicillin/streptomycin. BT-474 cells were further supplemented with 1 mM sodium pyruvate and 0.01 mg/ml bovine insulin. SK-BR-3 cells were maintained in McCoyâs 5A medium with 10% FCS, 1.5 mM L-glutamine and penicillin/streptomycin.!Sample_molecule_ch1 = genomic DNA!Sample_extract_protocol_ch1 = Genomic DNA was extracted using TRIzol and purified by chloroform extraction and subsequent ethanol precipitation.!Sample_label_ch1 = Cy3!Sample_label_protocol_ch1 = 3 Î¼g of digested sample or reference DNA (female genomic DNA, Promega) was labeled with Cy5-dUTP and Cy3-dUTP respectively using a Genomic DNA Enzymatic Labeling Kit.!Sample_source_name_ch2 = genomic DNA from breast cancer cell line KPL4!Sample_organism_ch2 = Homo sapiens!Sample_taxid_ch2 = 9606!Sample_characteristics_ch2 = gender: female!Sample_characteristics_ch2 = cell line: KPL4!Sample_growth_protocol_ch2 = MCF-7, KPL-4 and BT-474 cells were maintained in DMEM supplemented with 10% FBS, 2 mM (MCF-7, KPL-4) or 4 mM (BT-474) L-glutamine and penicillin/streptomycin. BT-474 cells were further supplemented with 1 mM sodium pyruvate and 0.01 mg/ml bovine insulin. SK-BR-3 cells were maintained in McCoyâs 5A medium with 10% FCS, 1.5 mM L-glutamine and penicillin/streptomycin.!Sample_molecule_ch2 = genomic DNA!Sample_extract_protocol_ch2 = Genomic DNA was extracted using TRIzol and purified by chloroform extraction and subsequent ethanol precipitation.!Sample_label_ch2 = Cy5!Sample_label_protocol_ch2 = 3 Î¼g of digested sample or reference DNA (female genomic DNA, Promega) was labeled with Cy5-dUTP and Cy3-dUTP respectively using a Genomic DNA Enzymatic Labeling Kit.!Sample_hyb_protocol = Labelled tumor and reference samples were combined and hybridized onto the arrays according to manufacturer's (Agilent) instructions. After hybridization, arrays were washed according to manufacturer's instructions.!Sample_scan_protocol = Arrays were scanned using a laser scanner from Agilent Technologies. Signal intensities were quantified using the Feature Extraction software from Agilent.!Sample_data_processing = Agilent Feature Extraction Software was used for spot quality filtering and normalization.!Sample_platform_id = GPL8736!Sample_contact_name = Henrik,,Edgren!Sample_contact_email = henrik.edgren@helsinki.fi!Sample_contact_institute = Institute for Molecular Medicine, University of Helsinki!Sample_contact_address = Tukholmankatu 8!Sample_contact_city = Helsinki!Sample_contact_zip/postal_code = 00290!Sample_contact_country = Finland!Sample_supplementary_file = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM590nnn/GSM590107/suppl/GSM590107_kpl4.130209_252152911062_S01_CGH_105_Dec08.txt.gz!Sample_series_id = GSE23949!Sample_data_row_count = 974016#ID_REF = #VALUE = normalized log10 ratio Cy5/Cy3!sample_table_beginID_REF	VALUE1	1.214695050e-0012	0.000000000e+0003	8.110422790e-0014	-1.271476411e-0015	-9.967882082e-0026	5.093173594e-0037	8.710228985e-0028	-1.555425905e-0019	8.589233231e-00210	2.002925894e-00111	1.567665071e-00212	2.898761727e-00213	2.774177084e-00114	7.423980980e-00215	2.422862290e-00216	1.755739614e-00217	-8.934147600e-00218	4.608649902e-00219	1.094015373e-00120	2.719475493e-001!sample_table_end